1. Home
  2. POLA vs CLDI Comparison

POLA vs CLDI Comparison

Compare POLA & CLDI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Polar Power Inc.

POLA

Polar Power Inc.

N/A

Current Price

$0.34

Market Cap

1.6M

Sector

Miscellaneous

ML Signal

N/A

Logo Calidi Biotherapeutics Inc.

CLDI

Calidi Biotherapeutics Inc.

N/A

Current Price

$0.55

Market Cap

1.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
POLA
CLDI
Founded
1979
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Miscellaneous
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6M
1.7M
IPO Year
2016
2021

Fundamental Metrics

Financial Performance
Metric
POLA
CLDI
Price
$0.34
$0.55
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 2.8M
32.2K
Earning Date
12-01-2026
11-13-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
★ $24,801,141.00
$45,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 3.14
N/A
52 Week Low
$0.26
$0.09
52 Week High
$3.25
$3.10

Technical Indicators

Market Signals
Indicator
POLA
CLDI
Relative Strength Index (RSI) 29.74 29.63
Support Level $0.27 $0.37
Resistance Level $1.93 $0.60
Average True Range (ATR) 0.07 0.07
MACD 0.02 0.00
Stochastic Oscillator 22.06 7.08

Price Performance

Historical Comparison
POLA
CLDI

About POLA Polar Power Inc.

Polar Power Inc is engaged in designing, manufacturing, and selling DC power generators, renewable energy, and cooling systems for applications in the telecommunications market and, to a lesser extent, in other markets, including military, electric vehicle, marine, and industrial. The company's products include DC generators, backup DC generators, hybrid power systems, Li-Ion battery systems, Marine DC generators, and others. The company's geographical presence is in the United States, Canada, Australia and South Pacific Islands, Other Asia Pacific, Europe and Middle East, United Kingdom, and South Africa.

About CLDI Calidi Biotherapeutics Inc.

Calidi Biotherapeutics Inc is a biotechnology company pioneering the development of targeted therapies with the potential to deliver genetic medicines to distal sites of disease. The company's proprietary RedTail platform features an engineered enveloped oncolytic virus designed for systemic delivery and targeting of metastatic sites. Its technology is intended to shield the virus from immune clearance, allowing virotherapy to effectively reach tumor sites, induce tumor lysis, and deliver potent genetic medicine(s) to metastatic locations. Its product candidates include The RedTail for Metastatic Solid Tumors, CLD-101 for Recurrent HGG; CLD-201 for Solid Tumors, and CLD-101 (NeuroNova) for Newly Diagnosed High Grade Glioma.

Share on Social Networks: